The Food and Drug Administration said Thursday it approved the emergency use of Pfizer's COVID-19 vaccine for children aged five to 11 years old, as the government sought to expand inoculations.
The Pfizer COVID-19 vaccine has an efficacy rate of above 90% among children five to 11 years old, with very mild adverse effects among the age group based on clinical trials, FDA director general Eric Domingo said during a public briefing.
"Nakita naman talaga natin na it is reasonable to believe that the vaccine may be effective to prevent COVID-19 and the benefits of vaccination outweigh the known and potential risks," he added.
The FDA earlier approved the emergency use of the Pfizer vaccine for minors 12 to 15 years old. Along with Moderna, it is now being used to inoculate minors against COVID-19.
ALSO READ:
Here's Your Guide to COVID Vaccines for Minors
12 to 15 Year-Olds with Comorbidities Can Get Pfizer COVID Vaccine, Says DOH
Reportr is now on Quento. Download the app or visit the Quento website for more articles and videos from Reportr and your favorite websites.
